Related Experiment Video

Updated: Nov 30, 2025

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
07:20

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Published on: June 14, 2018

12.8K

A knockout combination for MPN stem cells

Megan Bywater1,2, Steven W Lane1,2,3

  • 1Cancer Program, QIMR Berghofer Medical Research Institute, Herston, Australia.

The Journal of Experimental Medicine
|November 13, 2020
PubMed

Insights

This study shows combining arsenic and interferon alpha effectively targets myeloproliferative neoplasms (MPNs) stem cells. This breakthrough offers new hope for curing MPN blood cancers.

Area of Science:

  • Hematology
  • Oncology
  • Stem Cell Biology

Background:

  • Myeloproliferative neoplasms (MPNs) are stem cell-driven blood cancers.
  • Targeting MPN stem cells is crucial for achieving a cure.

Purpose of the Study:

  • To investigate the efficacy of a combination therapy targeting MPN stem cells.
  • To evaluate arsenic and interferon alpha as a potential treatment for MPNs.

Main Methods:

  • Utilized a combination of arsenic and interferon alpha.
  • Focused on eliminating myeloproliferative neoplasms stem cell populations.

Main Results:

  • The combined therapy demonstrated a significant impact on MPN stem cells.
  • This approach provides a potential strategy for eradicating the root cause of MPNs.

Conclusions:

  • Arsenic and interferon alpha combination therapy shows promise for curing MPNs.
  • This research offers new hope for patients with myeloproliferative neoplasms.

More Related Videos

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.5K
Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

6.9K

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K